These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20225009)

  • 1. In vitro pharmacological study of monomeric platinum(III) hematoporphyrin IX complexes.
    Momekov G; Karaivanova M; Ugrinova I; Pasheva E; Gencheva G; Tsekova D; Arpadjan S; Bontchev PR
    Invest New Drugs; 2011 Oct; 29(5):742-51. PubMed ID: 20225009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular Pharmacology of Palladinum(III) Hematoporphyrin IX Complexes: Solution Stability, Antineoplastic and Apoptogenic Activity, DNA Binding, and Processing of DNA-Adducts.
    Momekov G; Ugrinova I; Pasheva E; Tsekova D; Gencheva G
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure and in vitro cytotoxic studies of novel paramagnetic palladium(III) complexes with hematoporphyrin IX.
    Tsekova D; Gorolomova P; Gochev G; Skumryev V; Momekov G; Momekova D; Gencheva G
    J Inorg Biochem; 2013 Jul; 124():54-62. PubMed ID: 23603012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Structural Characterization, and Cytotoxic Activity of Novel Paramagnetic Platinum Hematoporphyrin IX Complexes: Potent Antitumor Agents.
    Gencheva G; Tsekova D; Gochev G; Momekov G; Tyuliev G; Skumryev V; Karaivanova M; Bontchev PR
    Met Based Drugs; 2007; 2007():67376. PubMed ID: 18309370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro biochemical and pharmacological evaluation of a novel cytotoxic dinuclear platinum(II) complex with 3-amino-5-methyl-5-phenylhydantoin.
    Momekov GTs; Ugrinova I; Pasheva EA; Bakalova AG; Varbanov HP; Ferdinandov DV; Ivanov DS; Konstantinov SM
    Ann N Y Acad Sci; 2009 Aug; 1171():649-58. PubMed ID: 19723116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
    Yamada K; Kato N; Takagi A; Koi M; Hemmi H
    Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
    Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
    Shahsavar F; Bozorgmehr M; Mirzadegan E; Abedi A; Lighvan ZM; Mohammadi F; Safari N; Amani V; Zarnani AH
    Anticancer Agents Med Chem; 2016; 16(3):393-403. PubMed ID: 26899296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.
    Gao E; Liu L; Zhu M; Huang Y; Guan F; Gao X; Zhang M; Wang L; Zhang W; Sun Y
    Inorg Chem; 2011 Jun; 50(11):4732-41. PubMed ID: 21520903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential toxic effect of cis-platinum(II) and palladium(II) chlorides complexed with methyl 3,4-diamine-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside in mouse lymphoma cell lines differing in DSB and NER repair ability.
    Kruszewski M; Bouzyk E; Oldak T; Samochocka K; Fuks L; Lewandowski W; Fokt I; Priebe W
    Teratog Carcinog Mutagen; 2003; Suppl 1():1-11. PubMed ID: 12616592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures and cytotoxicity of isopropylamine Pt(II) complexes: a trinuclear squarato-bridged [Pt3(mu2-C4O4)3(H2NPri)6].3H2O and a mononuclear cis-[Pt(NO3)2(H2NPri)2].
    Grabner S; Modec B; Cemazar M; Bukovec N
    J Inorg Biochem; 2005 Jul; 99(7):1465-71. PubMed ID: 15927264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring Pt II chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand.
    Kasparkova J; Suchankova T; Halamikova A; Zerzankova L; Vrana O; Margiotta N; Natile G; Brabec V
    Biochem Pharmacol; 2010 Feb; 79(4):552-64. PubMed ID: 19782655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of a stable monomeric gold(II) complex with hematoporphyrin IX: cytotoxicity against tumor and kidney cells, cellular accumulation, and induction of apoptosis.
    Momekov G; Ferdinandov D; Konstantinov S; Arpadjan S; Tsekova D; Gencheva G; Bontchev PR; Karaivanova M
    Bioinorg Chem Appl; 2008; 2008():367471. PubMed ID: 18497870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding {(N), (N,O)- or (C,N)}- of (1S,2R)[(η5-C5H5)Fe{(η5-C5H4)CHNCH(Me)CH(OH)C6H5}] and the arrangement of the auxiliary ligands.
    Talancón D; López C; Font-Bardía M; Calvet T; Quirante J; Calvis C; Messeguer R; Cortés R; Cascante M; Baldomà L; Badia J
    J Inorg Biochem; 2013 Jan; 118():1-12. PubMed ID: 23123334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel bis-platinum complexes endowed with an improved pharmacological profile.
    Gatti L; Perego P; Leone R; Apostoli P; Carenini N; Corna E; Allievi C; Bastrup U; De Munari S; Di Giovine S; Nicoli P; Grugni M; Natangelo M; Pardi G; Pezzoni G; Singer JW; Zunino F
    Mol Pharm; 2010 Feb; 7(1):207-16. PubMed ID: 19919086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships.
    Navarro JA; Salas JM; Romero MA; Vilaplana R; Gonzalez-Vílchez F; Faure R
    J Med Chem; 1998 Jan; 41(3):332-8. PubMed ID: 9464364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.